IX Biopharma (42C): IX BIOPHARMA LTD. Price Target

Highlights

Stock Price Target

Last Price	Avg Target Price	Upside/Downside	Price Call
0.191	0.37	+0.179 (93.72%)

* Average Target Price, Price Call and Upside/Downside are derived from Price Targets in the past 6 months.

** Price Targets are adjusted for Bonus Issue, Shares Split & Shares Consolidation (where applicable).

Date	Open Price	Target Price	Upside/Downside	Price Call	Source
29/11/2021	0.23	0.35	+0.12 (52.17%)	BUY	PHILLIP CAPITAL
20/10/2021	0.235	0.33	+0.095 (40.43%)	BUY	PHILLIP CAPITAL
14/06/2021	0.235	0.44	+0.205 (87.23%)	BUY	PHILLIP CAPITAL
08/04/2021	0.25	0.44	+0.19 (76.00%)	BUY	PHILLIP CAPITAL
19/02/2021	0.255	0.44	+0.185 (72.55%)	BUY	PHILLIP CAPITAL

Price Target Research Article/News (past 6 months)
29/11/2021	PHILLIP CAPITAL	IX Biopharma Ltd – Just a Warm Up
20/10/2021	PHILLIP CAPITAL	IX Biopharma Ltd – Multiple Share Price Catalyst
14/06/2021	PHILLIP CAPITAL	IX Biopharma Ltd – Product and Capacity Momentum
08/04/2021	PHILLIP CAPITAL	IX Biopharma Ltd. Fanning Out in China
19/02/2021	PHILLIP CAPITAL	IX Biopharma Ltd. – Delayed Profitability

Be the first to like this.

APPS

I3 Messenger

Individual or Group chat with anyone on I3investor

156

263

224

569

ActiveGainersLosers

TOP ARTICLES

1.	Why I Sold Mapletree North Asia Commercial Trust (MNACT) Shares at $1.10 Dividend Titan
2.	7 Reminders During A Correction Singapore Humble Stock
3.	Mapletree Commercial Trust's Q3 and 9M FY2021/22 Business Updates - What You Need to Know THE SINGAPOREAN INVESTOR
4.	Novo Tellus Alpha Acquisition (NTAA) - Riding the Technology Frontier - Lists on SGX SGX Market Updates
5.	A Summary of Frasers Centrepoint Trust's Business Updates for Q1 FY2021/22 THE SINGAPOREAN INVESTOR

PARTNERS & BROKERS